Saint-Priest, France

Lars Petter Jordheim

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Ecole Normale Superieure De Lyon, Hospices Civils De Lyon. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lars Petter Jordheim. Retrieved from https://idiyas.com/inventor/lars-petter-jordheim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lars Petter Jordheim: Innovator in Cancer Treatment

Introduction

Lars Petter Jordheim is a notable inventor based in Saint-Priest, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic compounds.

Latest Patents

Jordheim holds a patent for "5'-nucleotidase inhibitors and therapeutic uses thereof." This invention involves compounds with a 6-aminopurine backbone, which are designed for use in the treatment of cancer. The patent outlines specific structural formulas and therapeutic applications that could potentially enhance cancer treatment options.

Career Highlights

Throughout his career, Lars Petter Jordheim has worked with esteemed organizations such as the Centre National De La Recherche Scientifique and Hospices Civils De Lyon. His work in these institutions has allowed him to advance his research and contribute to significant medical advancements.

Collaborations

Jordheim has collaborated with notable colleagues, including Laurent Chaloin and Suzanne Peyrottes. These partnerships have fostered a collaborative environment that enhances innovation and research in the field of cancer therapeutics.

Conclusion

Lars Petter Jordheim's contributions to cancer treatment through his patented inventions and collaborative efforts highlight his role as a significant innovator in the medical field. His work continues to inspire advancements in therapeutic applications for cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…